Work

Figure S1 from Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma

Year: 2023

Type: other

Abstract: Tumor mutational age (TMB) by age (p=0.58 for fusion-negative patients, Pearson coefficient = -0.07, R2 = 0.005; and p=0.04 for fusion-positive patients, Pearson coefficient = 0.44, R2 = 0.20)

DOI: 10.1158/1078-0432.22476552.v1

Authors: Dana L. Casey, Leonard H. Wexler, Kenneth L. Pitter, Robert M. Samstein, Emily K. Slotkin, Suzanne L. Wolden

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361937124

Cites:

Cited by:

Related to: 10